Italia markets open in 3 hours 29 minutes

SWTX Jun 2024 40.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,90000,0000 (0,00%)
In data: 11:59AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,9000
Aperto1,9000
Denaro0,0000
Domanda4,6000
Prezzo d'esercizio40,00
Scadenza2024-06-21
Min-Max giorno1,9000 - 1,9000
Contratto - Min-MaxN/D
Volume1
Open Interest458
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (